These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1931452)

  • 21. American symposium looks at new antineoplastic drug.
    Korcok M
    Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
    [No Abstract]   [Full Text] [Related]  

  • 22. Anthracyclines in Nijmegen breakage syndrome.
    Barth E; Demori E; Pecile V; Zanazzo GA; Malorgio C; Tamaro P
    Med Pediatr Oncol; 2003 Feb; 40(2):122-4. PubMed ID: 12461799
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
    Campora E; Nobile MT; Sertoli MR; Rosso R
    Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of anthracyclines with covalently closed circular DNA.
    Mong S; DuVernay VH; Strong JE; Crooke ST
    Mol Pharmacol; 1980 Jan; 17(1):100-4. PubMed ID: 6155600
    [No Abstract]   [Full Text] [Related]  

  • 25. [A phase I trial of 4'-epiadriamycin].
    Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anthracycline antibiotics in treatment of neoplasms].
    Błaszczyk F; Kowalski DM
    Pol Merkur Lekarski; 1997 May; 2(11):331-5. PubMed ID: 9377684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposomal doxorubicin.
    Linsky KF; Ignoffo RJ
    Cancer Pract; 1996; 4(5):288-90. PubMed ID: 9004577
    [No Abstract]   [Full Text] [Related]  

  • 28. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
    Minisini AM; Andreetta C; Fasola G; Puglisi F
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance of anthracyclines in tumors of the ovary and endometrium and soft tissue sarcomas].
    Mignot L
    Pathol Biol (Paris); 1987 Jan; 35(1):118-22. PubMed ID: 3550606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rodorubicin, a new tetraglycosidic anthracycline.
    Kraemer HP; Sedlacek HH
    Behring Inst Mitt; 1988 Apr; (82):216-30. PubMed ID: 3165634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anthracyclines.
    Myers CE
    Cancer Chemother Biol Response Modif; 1992; 13():45-52. PubMed ID: 1389917
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of paclitaxel or doxorubicin used as single agents in advanced breast cancer: a literature survey.
    Paridaens R
    Semin Oncol; 1998 Oct; 25(5 Suppl 12):3-6. PubMed ID: 9865704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials.
    Mehta RS; Schubbert T
    J Natl Cancer Inst; 2008 May; 100(9):680; author reply 680-1. PubMed ID: 18445822
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ovarian carcinoma. Residual therapy with pegylated liposomal doxorubicin?].
    Musch A
    Med Monatsschr Pharm; 2005 Dec; 28(12):453-5. PubMed ID: 16389880
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
    Animati F; Arcamone F; Bigioni M; Capranico G; Caserini C; De Cesare M; Lombardi P; Pratesi G; Salvatore C; Supino R; Zunino F
    Mol Pharmacol; 1996 Sep; 50(3):603-9. PubMed ID: 8794900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.
    Ogawara K; Un K; Tanaka K; Higaki K; Kimura T
    J Control Release; 2009 Jan; 133(1):4-10. PubMed ID: 18840484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826).
    Woessner R; An Z; Li X; Hoffman RM; Dix R; Bitonti A
    Anticancer Res; 2000; 20(4):2289-96. PubMed ID: 10953287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin in combination chemotherapy for breast cancer: a preliminary report.
    Ward HW
    Br J Clin Pract; 1974 Apr; 28(4):137-8. PubMed ID: 4841023
    [No Abstract]   [Full Text] [Related]  

  • 39. Caelyx and ovarian cancer.
    Eur J Cancer Care (Engl); 2001 Jun; 10(2):79. PubMed ID: 11829050
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer.
    Pérez-López ME; Curiel T; Gómez JG; Jorge M
    Anticancer Drugs; 2007 Jun; 18(5):611-7. PubMed ID: 17414631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.